Concussion Treatment in Older Adults

Description

The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with the participant's second concussion clinical visit, typically (but not limited to) between 21-31 days from V1.

Conditions

Concussion, Mild

Study Overview

Study Details

Study overview

The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with the participant's second concussion clinical visit, typically (but not limited to) between 21-31 days from V1.

Randomized Controlled Trial of Targeted Treatment in Older Adults Following Concussion

Concussion Treatment in Older Adults

Condition
Concussion, Mild
Intervention / Treatment

-

Contacts and Locations

Pittsburgh

University of Pittsburgh, Pittsburgh, Pennsylvania, United States, 15203

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 50 years of age or older
  • * Diagnosed concussion within the last 4 days - 12 months
  • * Must be recruited at their initial concussion appointment
  • * Ability to read/write to complete study assessments/testing
  • * Diagnosed neurological disorder (stroke, dementia, epilepsy)
  • * Diagnosed major psychiatric disorders other than depression/anxiety (e.g., schizophrenia)
  • * Diagnosed with moderate to severe brain injury or past brain surgery/malformations

Ages Eligible for Study

50 Years to 99 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pittsburgh,

Anthony Kontos, PhD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

2024-12